Learn More
Recombinant antibody phage display technology is a vital tool that facilitates identification of specific binding molecules to a target enabling the rapid generation and selection of high affinity, fully human, or mouse antibody product candidates essentially directed towards disease target appropriate for antibody therapy. In this study, a recombinant(More)
Bovine tuberculosis (bTB) leads to morbidity, mortality and economic losses worldwide and can be controlled by detection and removal of infected animals. Bovigam™, based on IFN-γ release assays, (IGRAs) has been recently approved as an ancillary diagnostic test to the conventional tuberculin skin test (TST). The assay, which is costly kit is based on the(More)
  • 1